top of page
DRAIGON homepage.png

Advanced AMR diagnostics...

Anywhere the patient is...

Icon
missing
Icon
missing

The project aims to enable vital ‘near patient’ rapid and accurate diagnosis. 

Antibiotic resistance threatens our ability to treat common infections. 

Combining the latest in diagnostic technology and cloud-based AI bioanalytics.

Delivering precise, effective diagnosis, exactly where needed, leading to rapid treatment and improved patient outcomes

We invite you to be part of this ground-breaking initiative.

Whether you're a healthcare professional, researcher, or simply passionate about global health, there are many ways to engage with the DRAIGON Consortium:

DRAIGON lab2_edited.jpg
AdobeStock_688236165 2.png
Team celebrating.png

Research projects

 

Find out more about our pioneering AMR diagnostic tests for blood stream infections (BSI) and periprosthetic joint infections (PJI).

News and publications

Keep up-to-date with our latest news, articles and scientific publications.

Partners and governance

All about DRAIGON’s background, mission, governance, partnering members and impact statement.

Group 34.png
BG path 2_edited.png

Why should we care about antimicrobial resistance?

A top global health threat



 

AMR is ranked as 1 of the top global public health threats 
by the World Health Organization (WHO).

A top European health threat

In 2023 the European Parliament recognised AMR as one of the top 3 priority health threats in the EU.

4.95 million global deaths in 2019

 

AMR contributed to 4.95 million global deaths in 2019 and was 
directly responsible for 1.27 million global deaths.

Together, We Can Make a Difference:

Join us in our mission to combat antibiotic resistance and safeguard the health of future generations. Together, we can pioneer new approaches, drive innovation, and ultimately save lives.

The emergence and spread of antimicrobial resistance are caused by human activity, particularly the excessive use of antimicrobials for treating, preventing, or controlling infections in humans, animals, and plants. As a result, antimicrobial drugs become ineffective against microorganisms, and subsequently, infections become difficult to treat or even untreatable.

 

This in turn increases the risk of:
 

          Severe illness

          Disability
          Death
          Further spread of AMR (antimicrobial resistance)

DRAIGON funders

EN_FundedbytheEU_RGB_PORTFOLIO.png
UKRI_Horizontal_RGB.png
bottom of page